Bivin & Associates, Inc. Harrow Health, Inc. Transaction History
Bivin & Associates, Inc.
- $93.1 Million
- Q2 2022
Shares
2 transactions
Others Institutions Holding HROW
# of Institutions
187Shares Held
21.1MCall Options Held
679KPut Options Held
1.27M-
Opaleye Management Inc. Boston, MA3.99MShares$97.4 Million26.33% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$52.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$45.7 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.69MShares$41.4 Million6.85% of portfolio
-
Braidwell LP Stamford, CT907KShares$22.1 Million1.7% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $661M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...